pubmed-article:18841456 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18841456 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
pubmed-article:18841456 | lifeskim:mentions | umls-concept:C0004268 | lld:lifeskim |
pubmed-article:18841456 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:18841456 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:18841456 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:18841456 | pubmed:dateCreated | 2009-7-17 | lld:pubmed |
pubmed-article:18841456 | pubmed:abstractText | Background/Objectives Ingestion of the non-proteinic amino acid L-theanine (gamma-glutamylethylamide) has been shown to influence oscillatory brain activity in the alpha band (8-14 Hz) in humans during resting electroencephalographic (EEG) recordings and also during cognitive task performance. We have previously shown that ingestion of a 250-mg dose of L-theanine significantly reduced tonic (background) alpha power during a demanding intersensory (auditory-visual) attentional cueing task. Further, cue-related phasic changes in alpha power, indexing the shorter-term anticipatory biasing of attention between modalities, were stronger on L-theanine compared to placebo. This form of cue-contingent phasic alpha activity is also known to index attentional biasing within visual space. Specifically, when a relevant location is pre-cued, anticipatory alpha power increases contralateral to the location to be ignored. Here we investigate whether the effects of L-theanine on tonic and phasic alpha activity, found previously during intersensory attentional deployment, occur also during a visuospatial task. Subjects/Methods 168-channel EEG data were recorded from thirteen neurologically normal individuals while engaged in a highly demanding visuo-spatial attention task. Participants underwent testing on two separate days, ingesting either a 250-mg colorless and tasteless solution of L-theanine mixed with water, or a water-based solution placebo on each day in counterbalanced order. We compared the alpha-band activity when subjects ingested L-Theanine vs. Placebo. Results We found a significant reduction in tonic alpha for the L-theanine treatment compared to placebo, which was accompanied by a shift in scalp topography, indicative of treatment-related changes in the neural generators of oscillatory alpha activity. However, L-theanine did not measurably affect cue-related anticipatory alpha effects. Conclusions This pattern of results implies that L-theanine plays a more general role in attentional processing, facilitating longer-lasting processes responsible for sustaining attention across the timeframe of a difficult task, rather than affecting specific moment-to-moment phasic deployment processes. | lld:pubmed |
pubmed-article:18841456 | pubmed:language | eng | lld:pubmed |
pubmed-article:18841456 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18841456 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18841456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18841456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18841456 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18841456 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18841456 | pubmed:month | Jun | lld:pubmed |
pubmed-article:18841456 | pubmed:issn | 1573-6792 | lld:pubmed |
pubmed-article:18841456 | pubmed:author | pubmed-author:FoxeJohn JJJ | lld:pubmed |
pubmed-article:18841456 | pubmed:author | pubmed-author:KellySimon... | lld:pubmed |
pubmed-article:18841456 | pubmed:author | pubmed-author:Gomez-Ramirez... | lld:pubmed |
pubmed-article:18841456 | pubmed:author | pubmed-author:MontesiJennif... | lld:pubmed |
pubmed-article:18841456 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18841456 | pubmed:volume | 22 | lld:pubmed |
pubmed-article:18841456 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18841456 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18841456 | pubmed:pagination | 44-51 | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:meshHeading | pubmed-meshheading:18841456... | lld:pubmed |
pubmed-article:18841456 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:18841456 | pubmed:articleTitle | The effects of L-theanine on alpha-band oscillatory brain activity during a visuo-spatial attention task. | lld:pubmed |
pubmed-article:18841456 | pubmed:affiliation | Program in Cognitive Neuroscience and Schizophrenia, The Cognitive Neurophysiology Laboratory, Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA. | lld:pubmed |
pubmed-article:18841456 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18841456 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |